WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Partners, a strategic partner to leading life sciences
companies, today announced it has changed its brand identity to TRINITY
and launched its new website at trinitylifesciences.com.
The 20-year-old firm provides a range of integrated, evidence-based
solutions specifically designed and deployed to solve critical
commercialization challenges. TRINITY has grown to over 250
professionals, working with over 100 clients annually, including 18 of
the top 25 global biopharma manufacturers and dozens of leading medical
device and diagnostic companies.
The TRINITY name also highlights the company’s three-part foundation:
advisory services, insights & analytics, and technology. By
seamlessly integrating its knowledge through an evidence-based platform
called “TrinityEdge,” the company is able to meet the distinct needs of
both emerging biotech firms and established pharmaceutical companies.
“TRINITY is a natural evolution of our identity as a firm and an
exciting new brand for where we are headed,” said Dave Fitzhenry, Chief
Executive Officer of Trinity. “At TRINITY, we integrate data and
analytics to derive our own methodologies and platforms. Our solutions
truly fit customer needs and fulfill the promise of finding actionable
insights from the myriad data sources we have available to us in
healthcare. For TRINITY, it is about helping our clients through deep
business insights, applying our expertise with data, analytics, and
real-world evidence, and continuous innovation. We are set up to solve
highly complex analytical problems, as well as scale organizations from
research and development to full commercialization.”
TrinityEdge is the basis of all TRINITY’s work, empowering
differentiated insights that enable the team to solve critical
commercialization challenges. According to Fitzhenry, TrinityEdge
is an industry-leading platform that brings together the firm’s insights
and experience, data analytics, and technology to meet customers at
their point of need. “It’s what makes working with Trinity unlike
working with any other partner.”
To learn more about the new TRINITY:
-
Meet the TRINITY team and learn more about the company’s
evidence-based solutions at trinitylifesciences.com - Download the annual TRINITY Drug Index here.
-
Gain more information about TRINITY’s industry-leading benchmarking,
powered by TGaS -
Review insights, events and company highlights by following TRINITY on LinkedIn,
Twitter
About TRINITY
TRINITY is a trusted strategic partner, providing evidence-based
solutions for the life sciences. With over 20 years of experience,
TRINITY is committed to solving clients’ most challenging problems
through exceptional levels of service, powerful tools, and data-driven
insights.
TRINITY’s range of products and solutions includes industry-leading
benchmarking solutions, powered by TGaS. TRINITY, together with its
subsidiary TGaS® Advisors, has 5 offices throughout the US, including
Boston, New York, Princeton, Philadelphia, and San Francisco as well as
Toronto, Canada, and Gurgaon, India. TRINITY will be opening its first
European Office on July 1, 2019 in Munich, Germany. To learn more about
how TRINITY is elevating life sciences and driving from evidence to
action, visit trinitylifesciences.com
For media and general inquiries, contact Kirsten Brady, SVP Commercial,
Trinity. kbrady@trinitylifesciences.com;
973-223-6089
Contacts
Kirsten Brady
SVP Commercial, Trinity
kbrady@trinitylifesciences.com
973-223-6089